Premium
Lineage Cell Therapeutics Inc (LCTX)
AMEX
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Line... Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures. Show more
Lineage Has Now Received $30 Million in Gross Proceeds and May Receive an Additional $36 Million in Gross Proceeds Upon the Full Exercise of OpRegen® Clinical Milestone-linked Warrants Lineage...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today published a letter to...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.016001 | 2.48269976726 | 0.6445 | 0.6895 | 0.5761 | 1212536 | 0.6086311 | CS |
| 4 | 0.056401 | 9.33636815097 | 0.6041 | 0.6895 | 0.506 | 1691270 | 0.59549035 | CS |
| 12 | -0.280599 | -29.8160663054 | 0.9411 | 0.97 | 0.481 | 2793235 | 0.56778155 | CS |
| 26 | -0.238499 | -26.5293659622 | 0.899 | 0.97 | 0.481 | 1472971 | 0.62009764 | CS |
| 52 | -0.359499 | -35.245 | 1.02 | 1.61 | 0.481 | 1182090 | 0.81409014 | CS |
| 156 | -0.849499 | -56.2582119205 | 1.51 | 1.79 | 0.481 | 753047 | 1.06067726 | CS |
| 260 | -0.349499 | -34.6038613861 | 1.01 | 3.1316 | 0.481 | 904537 | 1.49387164 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| ETHU2x Ether ETF | US$ 4,535 (-36,75%) | 165,41M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 25,61 (-5,22%) | 103,91M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5,9602 (2,23%) | 91,52M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,54 (10,20%) | 86,35M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,77 (5,75%) | 79,38M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
